Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03190213 |
|---|---|
| Brief Title: | Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Carcinoma (Pembro NEC) |
| First Submitted : | June 13, 2017 |
| First Submitted that Met QC Criteria : | June 15, 2017 |
| First Posted : | June 16, 2017 |
| Results First Submitted : | December 10, 2019 |
| Results First Submitted that Met QC Criteria : | January 15, 2020 |
| Results First Posted : | January 27, 2020 |
| Last Update Submitted that Met QC Criteria : | June 18, 2021 |
| Last Update Posted : | June 22, 2021 |